DSM-Firmenich AG (AMS:DSFIR)
Netherlands · Delayed Price · Currency is EUR 109.75
+2.70 (2.52%)
Oct 19, 2026, 5:35 PM CET
DSM-Firmenich AG Revenue
DSM-Firmenich AG had revenue of 4.66B EUR in the half year ending June 30, 2026, a decrease of -25.94%. This brings the company's total for the last twelve months to 9.06B, down -18.75% year-over-year. In the year 2025, DSM-Firmenich AG had annual revenue of 9.03B, down -0.22%. That makes DSM-Firmenich AG the 1,442nd largest company in the world by revenue and 16th in the Netherlands.
Revenue (ttm)
9.06B
Revenue Growth
-18.75%
P/S Ratio
2.92
Revenue / Employee
435.63K
Employees
20,786
Market Cap
27.11B
Revenue by Segment
Fiscal year ended Dec 31, 2024 See the full DSM-Firmenich AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.03B | -20.00M | -0.22% |
| Dec 31, 2024 | 9.05B | -1.57B | -14.80% |
| Dec 31, 2023 | 10.63B | 2.24B | 26.66% |
| Dec 31, 2022 | 8.39B | 1.12B | 15.42% |
| Dec 31, 2021 | 7.27B | -837.00M | -10.33% |
| Dec 31, 2020 | 8.11B | 108.00M | 1.35% |
| Dec 31, 2019 | 8.00B | -1.27B | -13.69% |
| Dec 31, 2018 | 9.27B | 635.00M | 7.36% |
| Dec 31, 2017 | 8.63B | 712.00M | 8.99% |
| Dec 31, 2016 | 7.92B | -1.02B | -11.36% |
| Dec 31, 2015 | 8.94B | -348.00M | -3.75% |
| Dec 31, 2014 | 9.28B | -146.00M | -1.55% |
| Dec 31, 2013 | 9.43B | 298.00M | 3.26% |
| Dec 31, 2012 | 9.13B | -62.00M | -0.67% |
| Dec 31, 2011 | 9.19B | 143.00M | 1.58% |
| Dec 31, 2010 | 9.05B | 1.18B | 15.05% |
| Dec 31, 2009 | 7.87B | -1.43B | -15.39% |
| Dec 31, 2008 | 9.30B | 540.00M | 6.17% |
| Dec 31, 2007 | 8.76B | 377.00M | 4.50% |
| Dec 31, 2006 | 8.38B | 185.00M | 2.26% |
| Dec 31, 2005 | 8.20B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcelorMittal | 55.01B |
| Akzo Nobel | 9.89B |
| Aperam | 6.03B |
| IMCD N.V. | 4.97B |
| AMG Critical Materials | 1.62B |
| Corbion | 1.25B |
| OCI N.V. | 950.58M |
| Holland Colours | 109.01M |
DSM-Firmenich AG News
- 7 weeks ago - India investigates fragrance giants over price collusion, document shows - Reuters
- 2 months ago - Dsm-firmenich's fragrance-led core profit beat sends shares higher - Reuters
- 2 months ago - DSM-Firmenich AG Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - DSM-Firmenich AG Slides: Q2 2026 - Filings
- 2 months ago - DSM-Firmenich AG Earnings release: Q2 2026 - Filings
- 4 months ago - dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S. - GlobeNewsWire
- 5 months ago - dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam - GlobeNewsWire
- 5 months ago - dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2026 - GlobeNewsWire